CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands |
Total |
Class A |
Class C |
Conversion of common shares from Class C to Class A |
Conversion of common shares from Class C to Class A
Class A
|
Common Stock
Class A
|
Common Stock
Class C
|
Common Stock
Convertible Common Stock [Member]
|
Common Stock
Conversion of common shares from Class C to Class A
Class A
|
Common Stock
Conversion of common shares from Class C to Class A
Class C
|
Additional Paid-In Capital |
Additional Paid-In Capital
Conversion of common shares from Class C to Class A
|
Retained Earnings (Accumulated Deficit) |
Total Shareholder’s Equity |
Total Shareholder’s Equity
Conversion of common shares from Class C to Class A
|
Non-controlling Interest |
Non-controlling Interest
Conversion of common shares from Class C to Class A
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common shares outstanding at beginning of period (in shares) at Dec. 31, 2017 | 261,338,000 | 15,661,000 | |||||||||||||||
| Balance, beginning of period at Dec. 31, 2017 | $ 3,003,972 | $ 26 | $ 2 | $ 2,767,558 | $ 66,639 | $ 2,834,225 | $ 169,747 | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
| Conversion of common shares (in shares) | 3,658,000 | (3,658,000) | |||||||||||||||
| Conversion of common shares | $ 7,174 | $ 1 | $ (1) | $ 46,066 | $ 46,066 | $ (38,892) | |||||||||||
| Restricted stock issued (in shares) | 1,030,000 | ||||||||||||||||
| Restricted stock forfeited (in shares) | (136,000) | ||||||||||||||||
| Restricted stock used for tax withholding (in shares) | (91,000) | ||||||||||||||||
| Option exercises | (1,665) | (1,665) | (1,665) | ||||||||||||||
| Option exercises (in shares) | 60,000 | ||||||||||||||||
| Stock Issued During Period, Value, Stock Options Exercised | 982 | $ 0 | 982 | 982 | |||||||||||||
| Stock-based compensation | 20,670 | 20,670 | 20,670 | ||||||||||||||
| Net income (loss) | 212,736 | 199,899 | 199,899 | 12,837 | |||||||||||||
| Common shares outstanding at end of period (in shares) at Dec. 31, 2018 | 265,859,000 | 12,003,000 | |||||||||||||||
| Balance, end of period at Dec. 31, 2018 | 3,243,869 | $ 27 | $ 1 | 2,833,611 | 266,538 | 3,100,177 | 143,692 | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
| Conversion of common shares (in shares) | 10,969,064 | 10,969,000 | (10,969,000) | ||||||||||||||
| Conversion of common shares | (17,541) | $ 1 | (1) | 114,186 | 114,186 | (131,727) | |||||||||||
| Restricted stock issued (in shares) | 4,109,000 | ||||||||||||||||
| Restricted stock forfeited (in shares) | (116,000) | ||||||||||||||||
| Restricted stock used for tax withholding (in shares) | (171,000) | ||||||||||||||||
| Option exercises | (1,038) | (1,038) | (1,038) | ||||||||||||||
| Stock-based compensation | 28,997 | 28,997 | 28,997 | ||||||||||||||
| Net income (loss) | 16,414 | 15,798 | 15,798 | 616 | |||||||||||||
| Common shares outstanding at end of period (in shares) at Dec. 31, 2019 | 275,811,346 | 1,034,119 | 280,650,000 | 1,034,000 | |||||||||||||
| Balance, end of period at Dec. 31, 2019 | 3,270,701 | $ 28 | $ 0 | 2,975,756 | 282,336 | 3,258,120 | 12,581 | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
| Conversion of common shares (in shares) | 1,034,000 | (1,034,000) | |||||||||||||||
| Conversion of common shares | $ (2,208) | $ 0 | $ 0 | $ 8,011 | $ 8,011 | $ (10,219) | |||||||||||
| Restricted stock issued (in shares) | 10,246,000 | ||||||||||||||||
| Stock Issued During Period, Value, Restricted Stock Award, Gross | $ 1 | (1) | |||||||||||||||
| Restricted stock forfeited (in shares) | (897,000) | ||||||||||||||||
| Restricted stock used for tax withholding (in shares) | (550,000) | ||||||||||||||||
| Option exercises | (607) | (607) | (607) | ||||||||||||||
| Stock Issued During Period, Value, Employee Stock Purchase Plan | 308 | $ 0 | 308 | 308 | |||||||||||||
| Stock Issued During Period, Shares, Employee Stock Ownership Plan | 163,000 | ||||||||||||||||
| Stock-based compensation | 20,966 | 20,966 | 20,966 | ||||||||||||||
| Net income (loss) | (685,199) | (682,837) | (682,837) | (2,362) | |||||||||||||
| Common shares outstanding at end of period (in shares) at Dec. 31, 2020 | 278,551,901 | 0 | 290,646,000 | 0 | |||||||||||||
| Balance, end of period at Dec. 31, 2020 | $ 2,603,961 | $ 29 | $ 0 | $ 3,004,433 | $ (400,501) | $ 2,603,961 | $ 0 |